Dr. Brown-Glaberman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 University of New Mexico
1201 Camino de Salud MSC 074025
Albuquerque, NM 87131Phone+1 505-925-0404Fax+1 505-925-0408
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2010 - 2013- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2006 - 2010
University of New Mexico School of MedicineClass of 2006
Certifications & Licensure
NM State Medical License 2013 - 2025
AZ State Medical License 2009 - 2015
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014
Clinical Trials
- Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
- LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) Start of enrollment: 2014 Aug 25
- Join now to see all
Publications & Presentations
PubMed
- A Remotely Delivered Light-Intensity Physical Activity Intervention for Older Cancer Survivors: Protocol for a Feasibility Randomized Controlled Trial.Cindy K Blair, Ursa Brown-Glaberman, Scott T Walters, Claire Pestak, Tawny Boyce
JMIR Research Protocols. 2024-12-13 - NCCN Policy Summit: Cancer Across Geography.Sean T McCarson, Alyssa Schatz, Victoria Hood, Ashley Orr, Aaron Bailey
Journal of the National Comprehensive Cancer Network. 2024-05-31 - Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia
Cancer. 2024-05-15
Press Mentions
2-D or 3-D?October 16th, 2019- “Lobos Love Pink” Game Honors Breast Cancer Fighters and SurvivorsOctober 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
